Trading Ideas Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 06/12/2024 GMT			5-day change	1st Jan Change
1,549.00 ^DKK	-0.16%		+1.51%	-28.12%

12-04	Scancell Signs New Commercial License Deal With Genmab	MT
12-04	Scancell Holdings plc Announces Genmab Exercises Option to A Second Commercial License Agreement	CI

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GENMAB A/S: A trend reversal can be anticipated	08-27
GENMAB A/S: The comeback of an upward trend can be anticipated	03-11
GENMAB A/S: Expectation of a turn-around	01-25
GENMAB A/S: Expectation of a turn-around	01-04
GENMAB A/S: The comeback of an upward trend can be anticipated	12-08
GENMAB A/S: Technically solid	16/11/22
GENMAB A/S: Buyers are coming back	12/08/22
GENMAB A/S: Comeback of a rising trend?	31/03/22
GENMAB A/S: The underlying trend is to the upside	15/06/20
GENMAB A/S: The underlying trend is to the upside	31/01/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: Q3 profitability beat; lower end of the guidance upgraded

GENMAB : Q3 profitability beat; lower end of the guidance upgraded

November 07, 2024 at 08:46 pm

Stock markets for all